Skip to main content

Table 1 Definitions of indicators in Tables 3 and 4

From: Evaluation and pilot implementation of essential interventions for the management of hypertension and prevention of cardiovascular diseases in primary health care in the Republic of Tajikistan

Risk factors
Current smoker Proportions of smokers. Patients were assumed to be non-smokers if smoking status was not specified.
Diabetes Proportion of patients with a medical diagnosisa of diabetes mellitus. Patients were assumed to be non-diabetic if diabetes status was not specified.
History of CVD Proportion of patients with a medical diagnosisb of cardiovascular disease
SBP/DBP Mean based on the most recent systolic/diastolic blood pressure measurementc
Process indicators
Smoking status recorded Proportion of patients with smoking status recorded
BP measured regularly Proportion of patients with two documented BP measurementsc
Fasting glucose tested Proportions of patients with fasting glucose tested
Total cholesterol tested Proportions of patients with total cholesterol tested
WHO/ISH risk score documented Proportions of patients aged 40 years or more with a WHO/ISH CVD risk score documented by health workers based on age, sex, BP, smoking status, diabtes status, and total blood cholesterol
WHO/ISH risk score calculatable Proportions of patients aged 40 years or more with all risk factors (age, sex, BP, smoking status, diabetes status, and total blood cholesterol) recorded to calculated the WHO/ISH CVD risk score. Patients were assumed to be non-smoker if smoking status was not specified and to be non-diabetic if diabetes status was not specified. Predictions charts without total cholesterol were applied for those without measurement. The most recent BP and total cholesterol had to be during the last 24 months.
High-risk patients Proportions of patients with a calculatedd WHO/ISH ≥ 30 % or/and a history of CVD
BP lowering drug prescribed Proportions of patients with BP lowering drug prescribed
Statin prescribed for high-risk patients Proportions of high-risk patients (calculatedd WHO/ISH ≥ 30 % or/and history of CVD
Aspirin prescribed for high-risk patients Proportions of high-risk patients (calculatedd WHO/ISH ≥ 30 % or/and history of CVD) prescribed aspirin
Triple therapy prescribed for high-risk patients Proportions of high-risk patients (calculatedd WHO/ISH ≥ 30 % or/and history of CVD) prescribed triple therapy (statin, aspirin, and blood pressure medication)
Outcome indicator
BP at normal range Proportion of patients whose most recent BP measurementc was at normal range (SBP < 140 mmHg and DBP < 90 mmHg)
High-risk patients with BP at normal range Proportion of high-risk patients (calculatedd WHO/ISH ≥ 30 % or/and history of CVD) whose most recent BP measurementc was at normal range (SBP < 140 mmHg and DBP < 90 mmHg)
Low-risk patients with BP at normal range Proportion of low-risk patients (calculatedd WHO/ISH < 30 % and no history of CVD) whose most recent BP measurementc was at normal range (SBP < 140 mmHg and DBP < 90 mmHg)
  1. CVD cardiovascular disease; SBP systolic blood pressure; DBP diastolic blood pressure; BP blood pressure; WHO/ISH risk score, World Health Organization/International Society of Hypertension cardiovascular risk score.
  2. a Diagnoses written either using ICD-10 codes or as names of diseases to the section of permanent diagnoses in the patient records are taken into account.
  3. b Diagnoses written either using ICD-10 codes or as names of diseases or events in the patient records are taken into account.
  4. c Measured during the last 12 months.
  5. d Calculated by the authors of this study.